+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

From
Phototherapies For Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Phototherapies For Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Psoriasis Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Severe Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Systemic Psoriasis Therapeutics Market 2024-2028 - Product Thumbnail Image

Systemic Psoriasis Therapeutics Market 2024-2028

  • Report
  • October 2024
  • 213 Pages
  • Global
From
From
Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Moderate Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Moderate Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Moderate Psoriasis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Moderate Psoriasis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Plaque Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Plaque Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Psoriasis Pipeline Analysis Report 2025 - Product Thumbnail Image

Psoriasis Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Plaque Psoriasis Pipeline Analysis Report 2025 - Product Thumbnail Image

Plaque Psoriasis Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Severe Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Severe Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Erythrodermic Psoriasis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 52 Pages
  • Global
From
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 1218 Pages
  • Global
From
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more